Therapy of Lupus Nephritis

Howard A. Austin(National Institute of Arthritis and Musculoskeletal and Skin Diseases), John L. Decker(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Nicole G.H. Le Riche(National Institute of Arthritis and Musculoskeletal and Skin Diseases), James E. Balow(National Institute of Arthritis and Musculoskeletal and Skin Diseases), John H. Klippel(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Alfred D. Steinberg(Unknown), Paul H. Plötz(National Institutes of Health)
New England Journal of Medicine
March 6, 1986
10.1056/nejm198603063141004
Cited by 1,196

Related Papers

A New Approach to the Classification of Idiopathic Inflammatory Myopathy
|Medicine|1991|974
Defective Reticuloendothelial System Fc-Receptor Function in Systemic Lupus Erythematosus
|New England Journal of Medicine|1979|531
Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy
|The Journal of Experimental Medicine|2005|395
International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease
|Lara D. Veeken|2003|367
Suppression of autophagy in skeletal muscle uncovers the accumulation of ubiquitinated proteins and their potential role in muscle damage in Pompe disease
|Human Molecular Genetics|2008|349